Marco Ruella

Marco Ruella

University of Pennsylvania - Philadelphia / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 1530116
person_outline Marco Ruella's MOST POPULAR ARTICLES
1-) Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 ImmunotherapyAlternative Splicing of CD19 Enables Resistance to CART-19E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, ...Cancer discovery 5 (12), 1282-1295, 20159742015
2-) Human chimeric antigen receptor macrophages for cancer immunotherapyM Klichinsky, M Ruella, O Shestova, XM Lu, A Best, M Zeeman, ...Nature biotechnology 38 (8), 947-953, 20205492020
3-) Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapiesM Ruella, DM Barrett, SS Kenderian, O Shestova, TJ Hofmann, ...The Journal of clinical investigation 126 (10), 3814-3826, 20165082016
4-) Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cellM Ruella, J Xu, DM Barrett, JA Fraietta, TJ Reich, DE Ambrose, ...Nature medicine 24 (10), 1499-1503, 20185932018
5-) Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cellsS Gill, SK Tasian, M Ruella, O Shestova, Y Li, DL Porter, M Carroll, ...Blood, The Journal of the American Society of Hematology 123 (15), 2343-2354, 20145292014